IL1B and chronic obstructive pulmonary disease: The results indicated that BYF treatment markedly decreased the expression of IL-1β, IL-6, TNF-α, MMP-2, and MMP-9, and increased SOD2 expression in the lung tissues of COPD rats (Fig. 2).